Accuray posts losses for Q1

Accuray, a provider of radiosurgery systems, has reported its financial results for the first quarter of fiscal 2009, which ended Sept. 27.

The Sunnyvale, Calif.-based company said its net loss for the first quarter of fiscal 2009 was $3.2 million, compared to net income of $2.3 million, during the same period last year. Accuray said its loss for the quarter was driven primarily by non-recurring employee separation expenses of $2.1 million and inventory write downs of $1.3 million.

For the first quarter, Accuray said its total revenue of $55.9 million, a 15 percent increase over first quarter of fiscal 2008 total revenue of $48.6 million, and a 10 percent increase over the fourth quarter of fiscal 2008 total revenue of $50.9 million.

Accuray said its cash and investment balances at the end of the quarter totaled $162.1 million, which includes cash and cash equivalents of $27.2 million, short-term investments of $91.5 million, long-term investments of $38 million and $5.4 million in restricted cash. At the end of the first quarter, the company said it had zero debt.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.